ERN1 and Parkinson disease: Thus, inhibiting IRE1 or its downstream autophagic proteins (ATG7) ameliorated the progression of α-synuclein-caused Parkinson’s disease (Yan et al., 2019; Hetz et al., 2020; Kim et al., 2022).